| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.76 | 0.003 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.089 | 0.008 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.008 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.092 | 0.009 |